資源描述：
《臭氧治療膝關(guān)節(jié)創(chuàng)傷性滑膜炎的臨床研究.doc》由會員上傳分享，免費在線閱讀，更多相關(guān)內(nèi)容在工程資料-天天文庫。
1、臭氧治療膝關(guān)節(jié)創(chuàng)傷性滑膜炎的臨床研究【摘要】目的觀察臭氧治療膝關(guān)節(jié)創(chuàng)傷性滑膜炎的臨床療效。方法308例患者隨機分成臭氧治療組（n=156）和玻璃酸鈉組（n二152）,分別觀察兩組臨床療效、癥狀改善情況。結(jié)果①臨床近期療效比較：臭氧治療組總有效率為91.67%,玻璃酸鈉組總有效率為85.52%,兩組總有效率比較，差異有統(tǒng)計學(xué)意義（x2=9.984,P<0.01）；兩組臨床治愈率及顯效率比較，差異也有統(tǒng)計學(xué)意義（X2值分別為12.496和42.122,P<0.01）o②兩組癥狀改善比較：治療2個療程后，臭氧治療組局部腫脹、局部疼痛及膝部活動受限積分比較，差異有統(tǒng)
2、計學(xué)意義（P<0.01）o③兩組患者止痛時間及腫脹消退時間比較，差異有統(tǒng)計學(xué)意義（P<0.01）o④遠期療效：兩組不良反應(yīng)及后遺癥發(fā)生率比較，差異有統(tǒng)計學(xué)意義（PV0.01）。結(jié)論臭氧治療膝關(guān)節(jié)創(chuàng)傷性滑膜炎具有較好的臨床療效，是一種安全有效的新技術(shù)?！娟P(guān)鍵詞】膝滑膜炎；關(guān)節(jié)腔；創(chuàng)傷性；臭氧;玻璃酸鈉注射液文章編號：1003-1383(2011)05-0556-04中圖分類號：R684文獻標(biāo)識碼：Adoi:10.3969/j.issn.1003-1383.2011.05.004Clinicalresearchofozonetherapyontraumatics
3、ynovitisofkneejointsLIWenzhong?l,LIPu?2,ZHAOSuping?l,CHUQian?l,YANGLi?2(l.DepartmentofOrthopedics,HospitalofTCMofQiannanBuyiandMiaoAutonomousPrefecture,Duyun558000,Guizhou,China;2.QiannanMedicalCollegeforNationalities,Dunyun558001,Guizhou,China)[Abstract]ObjectiveToobservetheclinic
4、altherapeuticeffectofozoneontraumaticsynovitisofkneejoints.Methods308patientsweredividedintotwogroupsrandomly:theozonetreatmentgroup(n二156)andthesodiumhyaluronatetreatmentgroup(n=152).Theclinicaltherapeuticeffectandimprovementofsymptomsoftheparentsinbothgroupswereobservedrespective
5、!y.Results?Comparisonofrecentclinicaltherapeuticefficacy:thetotaleffectiverateofozonetreatmentgroupwas91.67%;thetotaleffectiverateofthesodiumhyaluronatetreatmentgroupwas85.52%?Therewassign訐icantstatisticaldiffereneebetweenbothgroupsintotaleffectiverate(x2=9.984,P<0.01).Therewassign
6、ificantstatisticaldiffereneebetweenbothgroupsinclinicalcurerateandmarkedlyeffectiverate(x2=12.49and42.12,PVO.01)?②Comparisonofimprovementofsymptomsofbothgroups:aftertwocoursesoftreatment,therewassign訐icantstatisticaldiffereneebetweenthescoresoflocalswelling，localpainandlimitedkneem
7、obilityintheozonetreatmentgroup(P<0.01).?Therewassign訐icantstatisticaldiffereneebetweenbothgroupsintherapeuticefficacyonpainandswelling(P<0.01).@Long-termtherapeuticefficacy:therewassignificantstatisticaldiffereneebetweenbothgroupsintermsofadversereactionsandoccurreneerateofsequela
8、(P<0.01).ConclusionOzoneha
